http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4079860-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f271d5f87b73c13fe71a3f02de2e6904
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14143
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-22
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-644
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-861
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-86
filingDate 2021-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03f470ccb42ff69c835e263a59e83836
publicationDate 2022-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-4079860-A1
titleOfInvention Methods and means for the prevention and/or treatment of joint damage in hemophilia
abstract The invention relates to a gene therapy vehicle for use in preventing, arresting and/or treating joint damage in mild, moderate and/or severe hemophilia B patients, wherein said gene therapy vehicle (comprises a nucleic acid that) encodes a coagulation factor having Factor IX activity.
priorityDate 2021-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010137211-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006036502-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2020129598-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020104480-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020104424-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID232

Total number of triples: 28.